Nakamura, Tomonori <br/><br/>
Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.  [electronic resource] 

 -  Biological & pharmaceutical bulletin  Jun 2006 
 - 1167-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1347-5215 
<br/><br/><label>Standard No.: </label>10.1248/bpb.29.1167  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Glucose--analysis<br/>Diabetes Mellitus, Experimental--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Dietary Fats--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drinking<br/>Drug Synergism<br/>Glucose Tolerance Test<br/>Glucose Transporter Type 4--metabolism<br/>Insulin--administration & dosage<br/>Insulin Receptor Substrate Proteins--metabolism<br/>Insulin Resistance<br/>Liver--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Niacinamide<br/>Pancreas--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Streptozocin<br/>Weight Gain